Expression of the Alzheimer amyloid-promoting factor antichymotrypsin is induced in human astrocytes by IL-1

[1]  W. Griffin,et al.  Microglial inter leukin‐1α expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution , 1995, Neuropathology and applied neurobiology.

[2]  T. Griffin,et al.  INTERLEUKIN-1α EXPRESSION IN BRAIN REGIONS IN ALZHEIMERʼS DISEASE: CORRELATION WITH NEURITIC PLAQUE DISTRIBUTION , 1995 .

[3]  H. Brewer,et al.  Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.

[4]  T Vogel,et al.  Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. , 1994, The American journal of pathology.

[5]  A. Roses,et al.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.

[6]  J Carter,et al.  Molecular Pathology of Alzheimer's Disease , 2013 .

[7]  R. Mangues,et al.  Brain interleukin-1 beta in Alzheimer's disease and vascular dementia. , 1994, Methods and findings in experimental and clinical pharmacology.

[8]  P. Fraser,et al.  An important role of heparan sulfate proteoglycan (perlecan) in a model system for the deposition and persistence of fibrillar aβ-amyloid in rat brain , 1994, Neuron.

[9]  R. Nelson,et al.  Identification of a Chymotrypsin‐Like Mast Cell Protease in Rat Brain Capable of Generating the N‐Terminus of the Alzheimer Amyloid β‐Protein , 1993, Journal of neurochemistry.

[10]  T. Wisniewski,et al.  Apolipoprotein E : binding to soluble Alzheimer's β-amyloid , 1993 .

[11]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Walker,et al.  Microglia in degenerative neurological disease , 1993, Glia.

[13]  G. Forloni,et al.  Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. , 1992, Brain research. Molecular brain research.

[14]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[15]  D. Dickson,et al.  Characterization of primary human fetal dissociated central nervous system cultures with an emphasis on microglia. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[16]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[17]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[18]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[19]  C. Cotman,et al.  β-Amyloid stimulates glial cells in vitro to produce growth factors that accumulate in senile plaques in Alzheimer's disease , 1992, Brain Research.

[20]  N. Otsuka,et al.  Rapid appearance of β-amyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury , 1991, Brain Research.

[21]  D. Price,et al.  Developmental expression of α1-antichymotrypsin in brain may be related to astrogliosis , 1991, Neurobiology of Aging.

[22]  P. Eikelenboom,et al.  Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin. , 1991, Acta neuropathologica.

[23]  D. Wirak.  Deposits of amyloid β protein in the central nervous system of transgenic mice , 1991 .

[24]  B. Trapp,et al.  Deposits of amyloid beta protein in the central nervous system of transgenic mice. , 1991, Science.

[25]  K. Murakami,et al.  Formation of β-amyloid protein deposits in brains of transgenic mice , 1991, Nature.

[26]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.

[27]  P. Eikelenboom,et al.  Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease , 1990, Neuroscience Letters.

[28]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[29]  R. Nixon,et al.  Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[30]  F. Petraglia,et al.  Dementia of the Alzheimer type and hypothalamus‐pituitary‐adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels , 1990, Acta neurologica Scandinavica.

[31]  R. Nelson,et al.  Clipsin, a chymotrypsin-like protease in rat brain which is irreversibly inhibited by alpha-1-antichymotrypsin. , 1990, Journal of Biological Chemistry.

[32]  H. Potter,et al.  α 1-Antichymotrypsin is associated solely with amyloid deposits containing the β-protein. Amyloid and cell localization of α 1-antichymotrypsin , 1990, Neurobiology of Aging.

[33]  D. Price,et al.  α1-Antichymotrypsin is present together with the β-protein in monkey brain amyloid deposits , 1989, Neuroscience.

[34]  R. Neve,et al.  The amyloid precursor protein is concentrated in neuronal lysosomes in normal and Alzheimer disease subjects , 1989, Experimental Neurology.

[35]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[36]  D. Selkoe,et al.  Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease , 1989, Journal of Neuroimmunology.

[37]  D. Selkoe,et al.  Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease , 1989, Nature.

[38]  Robert B. Nelson,et al.  Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage , 1989, Neuron.

[39]  D. Selkoe,et al.  Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. , 1989, The American journal of pathology.

[40]  D. Mann,et al.  AN ANALYSIS OF THE MORPHOLOGY OF SENILE PLAQUES IN DOWN'S SYNDROME PATIENTS OF DIFFERENT AGES USING IMMUNOCYTOCHEMICAL AND LECTIN HISTOCHEMICAL TECHNIQUES , 1989, Neuropathology and applied neurobiology.

[41]  L. Villa-komaroff,et al.  Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. , 1989, Science.

[42]  G. Glenner,et al.  Evidence of amyloid beta-protein immunoreactive early plaque lesions in Down's syndrome brains. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[43]  H. Baumann,et al.  Stimulation of Hepatic Acute Phase Response by Cytokines and Glucocorticoids a , 1989, Annals of the New York Academy of Sciences.

[44]  D. Selkoe,et al.  A CHARACTERISTIC BINDING AFFINITY BETWEEN HEPARAN SULFATE PROTEOGLYCANS AND THE A4 AMYLOID PROTEIN OF ALZHEIMERʼS DISEASE: 154 , 1989 .

[45]  S. Younkin,et al.  ASTROCYTES IN ALZHEIMER??S DISEASE GRAY MATTER EXPRESS ??1 ANTICHYMOTRYPSIN mRNA: 81 , 1989 .

[46]  C. Bouras,et al.  Down patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques , 1989, Neuroscience Letters.

[47]  H. Potter,et al.  Alzheimer's Disease: Recent Advances in Understanding the Brain Amyloid Deposits , 1989, Bio/Technology.

[48]  P. Eikelenboom,et al.  Complement activation in amyloid plaques in Alzheimer’s dementia , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[49]  D. Nochlin,et al.  The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. , 1988, The American journal of pathology.

[50]  L. G. Davis,et al.  Immunocytochemical localization of the precursor protein for β-amyloid in the rat central nervous system , 1988, Neuron.

[51]  W. Whetsell,et al.  Immunoreactive Epidermal Growth Factor Receptors in Neuritic Plaques from Patients with Alzheimer's Disease , 1988, Journal of neuropathology and experimental neurology.

[52]  R. Tanzi,et al.  Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease. , 1988, Science.

[53]  M. Nieto‐Sampedro.  Astrocyte mitogen inhibitor related to epidermal growth factor receptor. , 1988, Science.

[54]  D. Selkoe,et al.  Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease , 1988, Cell.

[55]  J. Morrison,et al.  Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Gauldie,et al.  Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. , 1987, Journal of immunology.

[57]  R. Rhodes,et al.  Immunohistochemical demonstration of proteinase inhibitor alpha‐1‐antichymotrypsin in normal human central nervous system , 1987, Journal of cellular biochemistry.

[58]  H. Wiśniewski,et al.  Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[59]  D. Price,et al.  Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. , 1987, Science.

[60]  M. Lerman,et al.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.

[61]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[62]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[63]  K. Davis,et al.  Cortisol and Alzheimer's disease, I: Basal studies. , 1986, The American journal of psychiatry.

[64]  D. Price,et al.  Senile plaques in cortex of aged normal monkeys , 1985, Brain Research.

[65]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[66]  L. Lachman,et al.  Interleukin-1 stimulation of astroglial proliferation after brain injury. , 1985, Science.

[67]  M. Esiri,et al.  Comparison of methods to identify microglial cells and macrophages in the human central nervous system. , 1984, Journal of clinical pathology.

[68]  M. Rapport,et al.  Glial fibrillary acidic protein and Alzheimer‐type senile dementia , 1980, Neurology.

[69]  G. Glenner.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts). , 1980, The New England journal of medicine.

[70]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[71]  H. Potter,et al.  The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease. , 1992, Progress in brain research.

[72]  K. Iqbal.  Alzheimer's disease : basic mechanisms, diagnosis and therapeutic strategies , 1991 .

[73]  S. Younkin,et al.  Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA. , 1989, The American journal of pathology.

[74]  J. Morrison,et al.  Differential regulation of amyloid β-protein mRNA expression within hippocampal neuronal sub-populations in Alzheimerʼs disease , 1988 .

[75]  D. Giulian.  Ameboid microglia as effectors of inflammation in the central nervous system , 1987, Journal of neuroscience research.

[76]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.

[77]  H. Wiśniewski,et al.  Morphology of the aging brain, human and animal. , 1973, Progress in brain research.